市場調査レポート
商品コード
1057457

ゲノミクスにおける人工知能の世界市場- 見通しと予測(2022年~2027年)

Artificial Intelligence in Genomics Market - Global Outlook & Forecast 2022-2027

出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 265 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
ゲノミクスにおける人工知能の世界市場- 見通しと予測(2022年~2027年)
出版日: 2022年02月09日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 265 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノミクスにおける人工知能の世界市場は、予測期間中に48.44%のCAGRで拡大すると予測されています。

創薬における人工知能は、その開発をより迅速かつ危険の少ないものにし、ひいては臨床医が複雑な疾患を遺伝子レベルで理解することを容易にしています。病気の診断やモニタリングのための新しく有利な用途の出現は、ゲノミクスにおける人工知能市場の成長をさらに促進すると予想されます。

当レポートでは、世界のゲノミクスにおける人工知能市場について調査し、市場の概要とともに、デリバリーモード別、機能別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 調査目的

第3章 調査プロセス

第4章 範囲と適用範囲

  • 市場の定義
  • 基準年
  • 調査範囲

第5章 レポートの前提条件と注意事項

第6章 市場の概要

第7章 イントロダクション

  • ヘルスケアにおけるAI
  • ゲノミクスにおけるAI

第8章 市場の機会と動向

  • 政府および民間企業による投資
  • 地方および地域の新興企業の出現
  • 製薬企業とソフトウェア企業のコラボレーション
  • 個別化/精密医療におけるMIの採用の増加

第9章 市場の促進要因

  • 創薬と診断におけるターンアラウンドタイムの短縮への注目の高まり
  • AIベースのソリューションの採用の拡大
  • 生物医学およびゲノムデータセットの増加

第10章 市場の抑制要因

  • 熟練した労働力とインフラの欠如
  • ゲノミクスソフトウェアのあいまいな規制ガイドライン
  • 不十分なセキュリティと大量のゲノムシーケンスデータの保存

第11章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第12章 デリバリーモード

  • 市場スナップショットと成長促進要因
  • 市場概要
  • オンプレミス
  • クラウドベース

第13章 機能

  • 市場スナップショットと成長促進要因
  • 市場概要
  • ゲノム配列決定
  • 遺伝子編集
  • その他

第14章 用途

  • 市場スナップショットと成長促進要因
  • 市場概要
  • トランスレーショナル精密医療
  • 臨床およびゲノム診断
  • その他

第15章 エンドユーザー

  • 市場スナップショットと成長促進要因
  • 市場概要
  • 製薬会社およびバイオテクノロジー企業
  • 公共および消費者ゲノムセンター
  • その他

第16章 地域

  • 市場スナップショットと成長促進要因
  • 地理的概要

第17章 北米

第18章 欧州

第19章 アジア太平洋

第20章 ラテンアメリカ

第21章 中東・アフリカ

第22章 競合情勢

第23章 主要な企業プロファイル

  • FABRIC GENOMICS
  • INTERNATIONAL BUSINESS MACHINES
  • MICROSOFT
  • NVIDIA

第24章 その他の著名なベンダー

  • AI THERAPEUTICS
  • ARES GENETICS
  • BENEVOLENTAI
  • DEEP GENOMICS
  • DIPLOID
  • DNANEXUS
  • EMEDGENE
  • EMPIRIC LOGIC
  • ENGINE BIOSCIENCES
  • FDNA
  • FREENOME HOLDINGS
  • GENUITY SCIENCE
  • LIFEBIT
  • MOLECULARMATCH
  • PREDICTIVE ONCOLOGY
  • SOPHIA GENETICS
  • VERGE GENOMICS
  • WHITELAB GENOMICS

第25章 レポートの概要

第26章 定量的サマリー

第27章 付録

  • 略語
図表

LIST OF EXHIBITS

  • Exhibit 1 Segmentation of Global AI in Genomics Market
  • Exhibit 2 Market Size Calculation Approach 2021
  • Exhibit 3 Impact of Investments by Government & Private Players
  • Exhibit 4 Impact of Emergence of Local and Regional Start-ups
  • Exhibit 5 Impact of Collaborations of Pharmaceutical and Software Companies
  • Exhibit 6 Impact of Rising Adoption of ML in Personalized/Precision Medicine
  • Exhibit 7 Impact of Rising Focus on Reducing Turnaround Time in Drugs Discovery & Diagnostics
  • Exhibit 8 Impact of Growing Adoption of AI-Based Solutions
  • Exhibit 9 Impact of Increased Biomedical and Genomic Datasets
  • Exhibit 10 Impact of Lack of Skilled Workforce & Infrastructure
  • Exhibit 11 Impact of Ambiguous Regulatory Guideline for Genomics Software
  • Exhibit 12 Impact of Poor Security & Storage of Larges Volume of Genome Sequencing Data
  • Exhibit 13 Global AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 14 Global AI in Genomics Market by Geography
  • Exhibit 15 Global AI in Genomics Market by Delivery Mode
  • Exhibit 16 Global AI in Genomics Market by Functionality
  • Exhibit 17 Global AI in Genomics Market by Application
  • Exhibit 18 Global AI in Genomics Market by End-User
  • Exhibit 19 Five Forces Analysis 2021
  • Exhibit 20 Incremental Growth by Delivery Mode 2021 & 2027
  • Exhibit 21 Global AI in Genomics Market by Delivery Mode
  • Exhibit 22 Global AI in Genomics Market by Delivery Mode: Incremental Growth
  • Exhibit 23 Global AI in Genomics Market by Delivery Mode: Absolute Growth
  • Exhibit 24 Global AI in Genomics Market by On-Premises: Incremental & Absolute Growth
  • Exhibit 25 Global On-Premises AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 26 Advantages of Implementing Cloud Computing
  • Exhibit 27 Global Cloud-Based AI in Genomics Market: Incremental & Absolute Growth
  • Exhibit 28 Global Cloud-Based AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 29 Incremental Growth by Functionality 2021 & 2027
  • Exhibit 30 Global AI in Genomics Market by Functionality
  • Exhibit 31 Global AI in Genomics Market by Functionality: Incremental Growth
  • Exhibit 32 Global AI in Genomics Market by Functionality: Absolute Growth
  • Exhibit 33 Global AI in Genomics Market by Genome Sequencing: Incremental & Absolute Growth
  • Exhibit 34 Global AI in Genomics Market by Genome Sequencing 2021-2027 ($ million)
  • Exhibit 35 Global AI in Genome Editing Market: Incremental & Absolute Growth
  • Exhibit 36 Global AI in Genomics Market by Gene Editing 2021-2027 ($ million)
  • Exhibit 37 Global AI in Genomics Market by Other Functionality: Incremental & Absolute Growth
  • Exhibit 38 Global AI in Genomics Market by Other Functionality 2021-2027 ($ million)
  • Exhibit 39 Incremental Growth by Application 2021 & 2027
  • Exhibit 40 Global AI in Genomics Market by Application
  • Exhibit 41 Global AI in Genomics Market by Application: Incremental Growth
  • Exhibit 42 Global AI in Genomics Market by Application: Absolute Growth
  • Exhibit 43 Vital Components in Translational Precision Medicine
  • Exhibit 44 Global AI in Genomics Market by Translational Precision Medicine: Incremental & Absolute Growth
  • Exhibit 45 Global AI in Genomics Market by Application: Translational Precision Medicine 2021-2027 ($ million)
  • Exhibit 46 Global AI in Genomics Market by Clinical & Genomic Diagnosis: Incremental & Absolute Growth
  • Exhibit 47 Global AI in Genomics Market by Clinical & Genomic Diagnosis 2021-2027 ($ million)
  • Exhibit 48 Global AI in Genomics Market by Other Applications: Incremental & Absolute Growth
  • Exhibit 49 Global AI in Genomics Market by Other Applications 2021-2027 ($ million)
  • Exhibit 50 Incremental Growth by End-User 2021 & 2027
  • Exhibit 51 Global AI in Genomics Market by End-User
  • Exhibit 52 Global AI in Genomics Market by End-User: Incremental Growth
  • Exhibit 53 Global AI in Genomics Market by End-User: Absolute Growth
  • Exhibit 54 Global AI in Genomics Market by Pharma & Biotech Companies: Incremental & Absolute Growth
  • Exhibit 55 Global AI in Genomics Market by Pharma & Biotech Companies 2021-2027 ($ million)
  • Exhibit 56 Global AI in Genomics Market by Public & Consumer Genomic Centers: Incremental & Absolute Growth
  • Exhibit 57 Global AI in Genomics Market by Public & Consumer Genomic Centers 2021-2027 ($ million)
  • Exhibit 58 Global AI in Genomics Market by Other End-Users: Incremental & Absolute Growth
  • Exhibit 59 Global AI in Genomics Market by Other End-Users 2021-2027 ($ million)
  • Exhibit 60 Incremental Growth by Geography 2021 & 2027
  • Exhibit 61 Global AI in Genomics Market by Geography
  • Exhibit 62 Global AI in Genomics Market by Geography: Incremental Growth
  • Exhibit 63 Global AI in Genomics Market by Geography: Absolute Growth
  • Exhibit 64 North America AI in Genomics Market: Incremental & Absolute Growth
  • Exhibit 65 North America AI in Genomics Market: Key Countries 2021
  • Exhibit 66 North America AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 67 Incremental Growth in North America 2021 & 2027
  • Exhibit 68 Use of AI in Healthcare Applications in US-2020 (%)
  • Exhibit 69 AI in Genomics Market in US 2021-2027 ($ million)
  • Exhibit 70 AI in Genomics Market in Canada 2021-2027 ($ million)
  • Exhibit 71 Europe AI in Genomics Market: Incremental & Absolute Growth
  • Exhibit 72 Europe AI in Genomics Market: Key Countries 2021
  • Exhibit 73 Europe AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 74 Incremental Growth in Europe 2021 & 2027
  • Exhibit 75 AI in Genomics Market in Germany 2021-2027 ($ million)
  • Exhibit 76 AI in Genomics Market in UK 2021-2027 ($ million)
  • Exhibit 77 AI in Genomics Market in France 2021-2027 ($ million)
  • Exhibit 78 AI in Genomics Market in Italy 2021-2027 ($ million)
  • Exhibit 79 AI in Genomics Market in Spain 2021-2027 ($ million)
  • Exhibit 80 APAC AI in Genomics Market: Incremental & Absolute Growth
  • Exhibit 81 APAC AI in Genomics Market: Key Countries 2021
  • Exhibit 82 APAC AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 83 Incremental Growth in APAC 2021 & 2027
  • Exhibit 84 AI in Genomics Market in Japan 2021-2027 ($ million)
  • Exhibit 85 AI in Genomics Market in China 2021-2027 ($ million)
  • Exhibit 86 AI in Genomics Market in India 2021-2027 ($ million)
  • Exhibit 87 AI in Genomics Market in Australia 2021-2027 ($ million)
  • Exhibit 88 AI in Genomics Market in South Korea 2021-2027 ($ million)
  • Exhibit 89 Latin America AI in Genomics Market: Incremental & Absolute Growth
  • Exhibit 90 Latin America AI in Genomics Market: Key Countries 2021
  • Exhibit 91 Latin America AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 92 Incremental Growth in Latin America 2021 & 2027
  • Exhibit 93 AI in Genomics Market in Brazil 2021-2027 ($ million)
  • Exhibit 94 AI in Genomics Market in Mexico 2021-2027 ($ million)
  • Exhibit 95 Middle East & Africa AI in Genomics Market: Incremental & Absolute Growth
  • Exhibit 96 Middle East & Africa AI in Genomics Market: Key Countries 2021
  • Exhibit 97 Middle East & Africa AI in Genomics Market 2021-2027 ($ million)
  • Exhibit 98 Incremental Growth in Middle East & Africa 2021 & 2027
  • Exhibit 99 AI in Genomics Market in Turkey 2021-2027 ($ million)
  • Exhibit 100 AI in Genomics Market in Saudi Arabia 2021-2027 ($ million)
  • Exhibit 101 AI in Genomics Market in South Africa 2021-2027 ($ million)
  • Exhibit 102 International Business Machines: Annual Revenue 2018-2020 ($ million)
  • Exhibit 103 International Business Machines Corporation.: Annual Revenue 2018-2020 ($ million)
  • Exhibit 104 Microsoft: Annul Revenue 2018-2020 ($ million)
  • Exhibit 105 Microsoft Corporation: R&D Spending 2018-2020 ($ million)
  • Exhibit 106 NVIDIA: Annual Revenue 2018-2020 ($ million)
  • Exhibit 107 NVIDIA: R&D Spending 2018-2020 ($ million)

LIST OF TABLES

  • Table 1 Key Caveats
  • Table 2 Currency Conversion 2015-2021
  • Table 3 Global On-Premises AI in Genomics Market by Geography 2021-2027 ($ million)
  • Table 4 Global On-Premises AI in Genomics Market by Geography 2021-2027 (%)
  • Table 5 Global Cloud-Based AI in Genomics Market by Geography 2021-2027 ($ million)
  • Table 6 Global Cloud-Based AI in Genomics Market by Geography 2021-2027 (%)
  • Table 7 Global AI in Genome Sequencing Market by Geography 2021-2027 ($ million)
  • Table 8 Global AI in Genome Sequencing Market by Geography 2021-2027 (% share)
  • Table 9 Global AI in Genomics Market by Gene Editing: Geography 2021-2027 ($ million)
  • Table 10 Global AI in Genomics Market by Gene Editing: Geography 2021-2027 (%)
  • Table 11 Global AI in Genomics Market by Other Functionality: Geography 2021-2027 ($ million)
  • Table 12 Global AI in Genomics Market by Other Functionality: Geography 2021-2027 (%)
  • Table 13 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021-2027 ($ million)
  • Table 14 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021-2027 (%)
  • Table 15 Global AI in Genomics Market by Clinical & Genomic Diagnosis: Geography 2021-2027 ($ million)
  • Table 16 Global AI in Genomics Market by Clinical & Genomic Diagnosis: Geography 2021-2027 (%)
  • Table 17 Global AI in Genomics Market by Other Applications: Geography 2021-2027 ($ million)
  • Table 18 Global AI in Genomics Market by Other Applications: Geography 2021-2027 (%)
  • Table 19 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021-2027 ($ million)
  • Table 20 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021-2027 (%)
  • Table 21 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021-2027 ($ million)
  • Table 22 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021-2027 (%)
  • Table 23 Global AI in Genomics Market by Other End-Users: Geography 2021-2027 ($ million)
  • Table 24 Global AI in Genomics Market by Other End-Users: Geography 2021-2027 (%)
  • Table 25 North America AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 26 North America AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 27 North America AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 28 North America AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 29 North America AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 30 North America AI in Genomics Market by Application 2021-2027 (%)
  • Table 31 North America AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 32 North America AI in Genomics Market by End-User 2021-2027 (%)
  • Table 33 Europe AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 34 Europe AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 35 Europe AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 36 Europe AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 37 Europe AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 38 Europe AI in Genomics Market by Application 2021-2027 (%)
  • Table 39 AI in Genomics Market in Europe by End-User 2021-2027 ($ million)
  • Table 40 AI in Genomics Market in Europe by End-User 2021-2027 (%)
  • Table 41 APAC AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 42 APAC AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 43 APAC AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 44 APAC AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 45 APAC AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 46 APAC AI in Genomics Market by Application 2021-2027 (%)
  • Table 47 APAC AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 48 APAC AI in Genomics Market by End-User 2021-2027 (%)
  • Table 49 AI in Genomics Market in Latin America by Delivery Mode 2021-2027 ($ million)
  • Table 50 AI in Genomics Market in Latin America by Delivery Mode 2021-2027 (%)
  • Table 51 Latin America AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 52 Latin America AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 53 Latin America AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 54 Latin America AI in Genomics Market by Application 2021-2027 (%)
  • Table 55 Latin America AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 56 AI in Genomics Market in Latin America by End-User 2021-2027 (%)
  • Table 57 Middle East & Africa AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 58 Middle East & Africa AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 59 Middle East & Africa AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 60 Middle East & Africa AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 61 Middle East & Africa AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 62 Middle East & Africa AI in Genomics Market by Application 2021-2027 (%)
  • Table 63 Middle East & Africa AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 64 Middle East & Africa AI in Genomics Market by End-User 2021-2027 (%)
  • Table 65 Fabric Genomics: Major Product Offerings
  • Table 66 International Business Machines Corporation: Major Product Offerings
  • Table 67 Microsoft: Major Product Offerings
  • Table 68 NVIDIA: Major Product Offerings
  • Table 69 AI Therapeutics: Major Product Offerings
  • Table 70 Ares Genetics: Major Product Offerings
  • Table 71 BenevolentAI: Major Product Offerings
  • Table 72 Deep Genomics: Major Product Offerings
  • Table 73 Diploid: Major Product Offerings
  • Table 74 DNAnexus: Major Product Offerings
  • Table 75 Emedgene: Major Product Offerings
  • Table 76 Empiric Logic: Major Product Offerings
  • Table 77 Engine Biosciences: Major Product Offerings
  • Table 78 FDNA: Major Product Offerings
  • Table 79 Freenome Holdings: Major Product Offerings
  • Table 80 Genuity Science: Major Product Offerings
  • Table 81 Lifebit: Major Product Offerings
  • Table 82 MolecularMatch: Major Product Offerings
  • Table 83 Predictive Oncology: Major Product Offerings
  • Table 84 SOPHiA GENETICS: Major Product Offerings
  • Table 85 Verge Genomics: Major Product Offerings
  • Table 86 WhiteLab Genomics: Major Product Offerings
  • Table 87 Global AI in Genomics Market by Geography 2021-2027 ($ million)
  • Table 88 Global AI in Genomics Market by Geography 2021-2027 (%)
  • Table 89 North America AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 90 North America AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 91 North America AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 92 North America AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 93 North America AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 94 North America AI in Genomics Market by Application 2021-2027 (%)
  • Table 95 North America AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 96 North America AI in Genomics Market by End-User 2021-2027 (%)
  • Table 97 Europe AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 98 Europe AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 99 Europe AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 100 Europe AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 101 Europe AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 102 Europe AI in Genomics Market by Application 2021-2027 (%)
  • Table 103 Europe AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 104 Europe AI in Genomics Market by End-User 2021-2027 (%)
  • Table 105 APAC AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 106 APAC AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 107 APAC AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 108 APAC AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 109 APAC AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 110 APAC AI in Genomics Market by Application 2021-2027 (%)
  • Table 111 APAC AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 112 APAC AI in Genomics Market by End-User 2021-2027 (%)
  • Table 113 Latin America AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 114 Latin America AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 115 Latin America AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 116 Latin America AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 117 Latin America AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 118 Latin America AI in Genomics Market by Application 2021-2027 (%)
  • Table 119 AI in Genomics Market in Latin America by End-User 2021-2027 ($ million)
  • Table 120 AI in Genomics Market in Latin America by End-User 2021-2027 (%)
  • Table 121 Middle East & Africa AI in Genomics Market by Delivery Mode 2021-2027 ($ million)
  • Table 122 Middle East & Africa AI in Genomics Market by Delivery Mode 2021-2027 (%)
  • Table 123 Middle East & Africa AI in Genomics Market by Functionality 2021-2027 ($ million)
  • Table 124 Middle East & Africa AI in Genomics Market by Functionality 2021-2027 (%)
  • Table 125 Middle East & Africa AI in Genomics Market by Application 2021-2027 ($ million)
  • Table 126 Middle East & Africa AI in Genomics Market by Application 2021-2027 (%)
  • Table 127 Middle East & Africa AI in Genomics Market by End-User 2021-2027 ($ million)
  • Table 128 Middle East & Africa AI in Genomics Market by End-User 2021-2027 (%)
  • Table 129 Global AI in Genomics Market by On-Premises: Geography 2021-2027 ($ million)
  • Table 130 Global AI in Genomics Market by On-Premises: Geography 2021-2027 (%)
  • Table 131 Global AI in Genomics Market by Cloud-Based: Geography 2021-2027 ($ million)
  • Table 132 Global AI in Genomics Market by Cloud-Based: Geography 2021-2027 (%)
  • Table 133 Global AI in Genomics Market by Genome Sequencing: Geography 2021-2027 ($ million)
  • Table 134 Global AI in Genomics Market by Genome Sequencing: Geography 2021-2027 (%)
  • Table 135 Global AI in Genomics Market by Gene Editing: Geography 2021-2027 ($ million)
  • Table 136 Global AI in Genomics Market by Gene Editing: Geography 2021-2027 (%)
  • Table 137 Global AI in Genomics Market by Other Functionality: Geography 2021-2027 ($ million)
  • Table 138 Global AI in Genomics Market by Other Functionality: Geography 2021-2027 (%)
  • Table 139 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021-2027 ($ million)
  • Table 140 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021-2027 (%)
  • Table 141 Global AI in Genomics Market by Clinical & Genomic Diagnostics: Geography 2021-2027 ($ million)
  • Table 142 Global AI in Genomics Market by Clinical & Genomic Diagnostics: Geography 2021-2027 (%)
  • Table 143 Global AI in Genomics Market by Other Applications: Geography 2021-2027 (%)
  • Table 144 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021-2027 ($ million)
  • Table 145 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021-2027 (%)
  • Table 146 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021-2027 ($ million)
  • Table 147 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021-2027 (%)
  • Table 148 Global AI in Genomics Market by Other End-Users: Geography 2021-2027 ($ million)
  • Table 149 Global AI in Genomics Market by Other End-Users: Geography 2021-2027 (%)
目次
Product Code: ARZ220102

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Artificial Intelligence in Genomics Market Report

The artificial intelligence in genomics market to grow at a CAGR of 48.44% during the forecast period

Artificial intelligence in drug discovery can make its development speedier and less hazardous which in turn is making it easy for clinicians to understand complicated diseases at the genetic level. The emergence of new and favorable applications for disease diagnosis and monitoring is expected to further drive the AI in genomics market growth. Several genomic-focused companies have shown favorable returns.

KEY HIGHLIGHTS

  • In 2017, liquid biopsy company GRAIL raised an unprecedented USD 914 million in its Series B round led by Smart Money VC ARCH Venture Partners and including Johnson & Johnson to continue product development and validation for its early-stage cancer detection blood test.
  • Another company that is making a lot of noise in the data-driven medicine space is Sophia Genetics from Switzerland. It already works with a half-dozen UK hospitals to pool data and bring AI-driven insights to cancer diagnostics, claiming to already diagnose hundreds of patients a day.

The following factors are likely to contribute to the growth of artificial intelligence in genomics market-

  • Rising Investment by Government & Private Players in Genomics
  • Emergence of Local and Regional Start-ups
  • Emergence of Local and Regional Start-ups
  • Rising Adoption of Machine Learning in Personalized/Precision Medicine
  • Rising Focus on Reducing the Turnaround Time in Drugs Discovery & Diagnostics

ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTS

AI in Genomics market is segmented by-

  • Delivery mode
  • Application
  • End-user
  • Geography

ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTATION

  • The on-premises segment accounted for a share of more than 60% of the global artificial intelligence (AI) in the genomics market in 2021. This is primarily attributed to the broad range of advantages associated with the use of on-premises software, such as high security of data, low risk of data breaches, and full command over software upgrades & data storage.
  • The closer combination of AI and gene sequencing will help in the development of the genome sequencing market. Companies such as Deep Genomics, use machine learning to support researchers interpret genetic variation.

Segmentation by Delivery Mode

  • On-Premises
  • Cloud-Based

Segmentation by Functionality

  • Genome Sequencing
  • Gene Editing
  • Others

Segmentation by Application

  • Translational Precision Medicine
  • Clinical & Genomic Diagnostics
  • Others

Segmentation by End User

  • Pharma & Biotech Companies
  • Public & Consumer Genomic Centers
  • Others

GEOGRAPHICAL OUTLOOK

North America: North America accounted for more than half of the share in the global artificial intelligence in the genomics market in 2021. The AI in genomics market is likely to increase in North America owing to the growing adoption of AI in genome sequencing and rising awareness among the regional pharma and biotech companies. AI deep learning algorithms have also saved many lives in North America by reducing the diagnosis-treatment-recovery cycle for patients.

Europe: The increased awareness among European patients drives the application of personal genome sequencing testing, especially for reproductive health. Artificial Intelligence (AI) is widely helping in diagnostics and contributing to accessible, affordable, and good quality healthcare, which is consequently improving accuracy.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

VENDOR LANDSCAPE

  • The key players in Artificial Intelligence in Genomics market are Fabric Genomics, International Business Machines, Microsoft, and
  • Vendors are increasingly focusing on launching innovative devices to penetrate and tap the huge growth potential prevailing in the market.

Key Vendors

  • Fabric Genomics
  • International Business Machines
  • Microsoft
  • NVIDIA

Other Prominent Vendors

  • AI Therapeutics
  • Ares Genetics
  • BenevolentAI
  • Deep Genomics
  • Diploid
  • DNAnexus
  • Emedgene
  • Empiric Logic
  • Engine Biosciences
  • FDNA
  • Freenome Holdings
  • Genuity Science
  • Lifebit
  • MolecularMatch
  • Predictive Oncology
  • SOPHiA GENETICS
  • Verge Genomics
  • WhiteLab Genomics

KEY QUESTIONS ANSWERED:

  • 1. What is the forecasted value of global Artificial Intelligence in genomics market size in 2027?
  • 2. What factors will drive Artificial Intelligence (AI) in genomics market?
  • 3. Who are the key players in Artificial Intelligence in genomics market?
  • 4. What is the post-pandemic scenario of the Artificial Intelligence in genomics market?
  • 5. What are some new product launches that created a buzz in the market?

TABLE OF CONTENTS

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

  • 4.1 Market Definition
    • 4.1.1 Inclusions
    • 4.1.2 Exclusions
    • 4.1.3 Market Estimation Caveats
  • 4.2 Base Year
  • 4.3 Scope of The Study
    • 4.3.1 Market Segmentation by Delivery Mode
    • 4.3.2 Market Segmentation by Functionality
    • 4.3.3 Market Segmentation by Application
    • 4.3.4 Market Segmentation by End-User
    • 4.3.5 Market Segmentation by Geography

5 Report Assumptions & Caveats

  • 5.1 Key Caveats
  • 5.2 Currency Conversion
  • 5.3 Market Derivation

6 Market at a Glance

7 Introduction

  • 7.1 AI in Healthcare
  • 7.2 AI in Genomics

8 Market Opportunities & Trends

  • 8.1 Investments by Government & Private Players
  • 8.2 Emergence of Local and Regional Start-Ups
  • 8.3 Collaborations of Pharmaceutical and Software Companies
  • 8.4 Rising Adoption of MI In Personalized/Precision Medicine

9 Market Growth Enablers

  • 9.1 Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics
  • 9.2 Growing Adoption of Ai-Based Solutions
  • 9.3 Increased Biomedical and Genomic Datasets

10 Market Restraints

  • 10.1 Lack of Skilled Workforce & Infrastructure
  • 10.2 Ambiguous Regulatory Guidelines for Genomics Software
  • 10.3 Poor Security & Storage of Large Volumes of Genome Sequencing Data

11 Market Landscape

  • 11.1 Market Overview
  • 11.2 Market Size & Forecast
    • 11.2.1 Geographic Insights
    • 11.2.2 Delivery Mode Insights
    • 11.2.3 Functionality Insights
    • 11.2.4 Application Insights
    • 11.2.5 End-User Insights
  • 11.3 Five Forces Analysis
    • 11.3.1 Threat of New Entrants
    • 11.3.2 Bargaining Power of Suppliers
    • 11.3.3 Bargaining Power of Buyers
    • 11.3.4 Threat of Substitutes
    • 11.3.5 Competitive Rivalry

12 Delivery Mode

  • 12.1 Market Snapshot & Growth Engine
  • 12.2 Market Overview
  • 12.3 On-Premises
    • 12.3.1 Market Overview
    • 12.3.2 Market Size & Forecast
    • 12.3.3 Market by Geography
  • 12.4 Cloud-Based
    • 12.4.1 Market Overview
    • 12.4.2 Market Size & Forecast
    • 12.4.3 Market by Geography

13 Functionality

  • 13.1 Market Snapshot & Growth Engine
  • 13.2 Market Overview
  • 13.3 Genome Sequencing
    • 13.3.1 Market Overview
    • 13.3.2 Market Size & Forecast
    • 13.3.3 Market by Geography
  • 13.4 Gene Editing
    • 13.4.1 Market Overview
    • 13.4.2 Market Size & Forecast
    • 13.4.3 Market by Geography
  • 13.5 Others
    • 13.5.1 Market Overview
    • 13.5.2 Market Size & Forecast
    • 13.5.3 Market by Geography

14 Application

  • 14.1 Market Snapshot & Growth Engine
  • 14.2 Market Overview
  • 14.3 Translational Precision Medicine
    • 14.3.1 Market Overview
    • 14.3.2 Market Size & Forecast
    • 14.3.3 Market by Geography
  • 14.4 Clinical & Genomic Diagnosis
    • 14.4.1 Market Overview
    • 14.4.2 Market Size & Forecast
    • 14.4.3 Market by Geography
  • 14.5 Other Applications
    • 14.5.1 Market Overview
    • 14.5.2 Market Size & Forecast
    • 14.5.3 Market by Geography

15 End-User

  • 15.1 Market Snapshot & Growth Engine
  • 15.2 Market Overview
  • 15.3 Pharma & Biotech Companies
    • 15.3.1 Market Overview
    • 15.3.2 Market Size & Forecast
    • 15.3.3 Market by Geography
  • 15.4 Public & Consumer Genomic Centers
    • 15.4.1 Market Overview
    • 15.4.2 Market Size & Forecast
    • 15.4.3 Market by Geography
  • 15.5 Others
    • 15.5.1 Market Overview
    • 15.5.2 Market Size & Forecast
    • 15.5.3 Market by Geography

16 Geography

  • 16.1 Market Snapshot & Growth Engine
  • 16.2 Geographic Overview

17 North America

  • 17.1 Market Overview
  • 17.2 Market Size & Forecast
  • 17.3 North America: Delivery Mode
    • 17.3.1 Market Size & Forecast
  • 17.4 North America: Functionality
    • 17.4.1 Market Size & Forecast
  • 17.5 North America: Application
    • 17.5.1 Market Size & Forecast
  • 17.6 North America: End-User
    • 17.6.1 Market Size & Forecast
  • 17.7 Key Countries
    • 17.7.1 US: Market Size & Forecast
    • 17.7.2 Canada: Market Size & Forecast

18 Europe

  • 18.1 Market Overview
  • 18.2 Market Size & Forecast
  • 18.3 Europe: Delivery Mode
    • 18.3.1 Market Size & Forecast
  • 18.4 Europe: Functionality
    • 18.4.1 Market Size & Forecast
  • 18.5 Europe: Application
    • 18.5.1 Market Size & Forecast
  • 18.6 Europe: End-User
    • 18.6.1 Market Size & Forecast
  • 18.7 Key Countries
    • 18.7.1 Germany: Market Size & Forecast
    • 18.7.2 UK: Market Size & Forecast
    • 18.7.3 France: Market Size & Forecast
    • 18.7.4 Italy: Market Size & Forecast
    • 18.7.5 Spain: Market Size & Forecast

19 APAC

  • 19.1 Market Overview
  • 19.2 Market Size & Forecast
  • 19.3 APAC: Delivery Mode
    • 19.3.1 Market Size & Forecast
  • 19.4 APAC: Functionality
    • 19.4.1 Market Size & Forecast
  • 19.5 APAC: Application
    • 19.5.1 Market Size & Forecast
  • 19.6 APAC: End-User
    • 19.6.1 Market Size & Forecast
  • 19.7 Key Countries
    • 19.7.1 Japan: Market Size & Forecast
    • 19.7.2 China: Market Size & Forecast
    • 19.7.3 India: Market Size & Forecast
    • 19.7.4 Australia: Market Size & Forecast
    • 19.7.5 South Korea: Market Size & Forecast

20 Latin America

  • 20.1 Market Overview
  • 20.2 Market Size & Forecast
  • 20.3 Latin America: Delivery Mode
    • 20.3.1 Market Size & Forecast
  • 20.4 Latin America: Functionality
    • 20.4.1 Market Size & Forecast
  • 20.5 Latin America: Application
    • 20.5.1 Market Size & Forecast
  • 20.6 Latin America: End-User
    • 20.6.1 Market Size & Forecast
  • 20.7 Key Countries
    • 20.7.1 Brazil: Market Size & Forecast
    • 20.7.2 Mexico: Market Size & Forecast

21 Middle East & Africa

  • 21.1 Market Overview
  • 21.2 Market Size & Forecast
  • 21.3 Middle East & Africa: Delivery Mode
    • 21.3.1 Market Size & Forecast
  • 21.4 Middle East & Africa: Functionality
    • 21.4.1 Market Size & Forecast
  • 21.5 Middle East & Africa: Application
    • 21.5.1 Market Size & Forecast
  • 21.6 Middle East & Africa: End-User
    • 21.6.1 Market Size & Forecast
  • 21.7 Key Countries
    • 21.7.1 Turkey: Market Size & Forecast
    • 21.7.2 Saudi Arabia: Market Size & Forecast
    • 21.7.3 South Africa: Market Size & Forecast

22 Competitive Landscape

  • 22.1 Competition Overview

23 Key Company Profiles

  • 23.1 FABRIC GENOMICS
    • 23.1.1 Business Overview
    • 23.1.2 Product Offerings
    • 23.1.3 Key Strategies
    • 23.1.4 Key Strengths
    • 23.1.5 Key Opportunities
  • 23.2 INTERNATIONAL BUSINESS MACHINES
    • 23.2.1 Business Overview
    • 23.2.2 Product Offerings
    • 23.2.3 Key Strategies
    • 23.2.4 Key Strengths
    • 23.2.5 Key Opportunities
  • 23.3 MICROSOFT
    • 23.3.1 Business Overview
    • 23.3.2 Product Offerings
    • 23.3.3 Key Strategies
    • 23.3.4 Key Strengths
    • 23.3.5 Key Opportunities
  • 23.4 NVIDIA
    • 23.4.1 Business Overview
    • 23.4.2 Product Offerings
    • 23.4.3 Key Strategies
    • 23.4.4 Key Strengths
    • 23.4.5 Key Opportunities

24 Other Prominent Vendors

  • 24.1 AI THERAPEUTICS
    • 24.1.1 Business Overview
    • 24.1.2 Product Offerings
  • 24.2 ARES GENETICS
    • 24.2.1 Business Overview
    • 24.2.2 Product Offerings
  • 24.3 BENEVOLENTAI
    • 24.3.1 Business Overview
    • 24.3.2 Product Offerings
  • 24.4 DEEP GENOMICS
    • 24.4.1 Business Overview
    • 24.4.1 Product Offerings
  • 24.5 DIPLOID
    • 24.5.1 Business Overview
    • 24.5.2 Product Offerings
  • 24.6 DNANEXUS
    • 24.6.1 Business Overview
    • 24.6.2 Product Offerings
  • 24.7 EMEDGENE
    • 24.7.1 Business Overview
    • 24.7.2 Product Offerings
  • 24.8 EMPIRIC LOGIC
    • 24.8.1 Business Overview
    • 24.8.2 Product Offerings
  • 24.9 ENGINE BIOSCIENCES
    • 24.9.1 Business Overview
    • 24.9.2 Product Offerings
  • 24.10 FDNA
    • 24.10.1 Business Overview
    • 24.10.2 Product Offerings
  • 24.11 FREENOME HOLDINGS
    • 24.11.1 Business Overview
    • 24.11.2 Product Offerings
  • 24.12 GENUITY SCIENCE
    • 24.12.1 Business Overview
    • 24.12.2 Product Offerings
  • 24.13 LIFEBIT
    • 24.13.1 Business Overview
    • 24.13.2 Product Offerings
  • 24.14 MOLECULARMATCH
    • 24.14.1 Business Overview
    • 24.14.2 Product Offerings
  • 24.15 PREDICTIVE ONCOLOGY
    • 24.15.1 Business Overview
    • 24.15.2 Product Offerings
  • 24.16 SOPHIA GENETICS
    • 24.16.1 Business Overview
    • 24.16.2 Product Offerings
  • 24.17 VERGE GENOMICS
    • 24.17.1 Business Overview
    • 24.17.2 Product Offerings
  • 24.18 WHITELAB GENOMICS
    • 24.18.1 Business Overview
    • 24.18.2 Product Offerings

25 Report Summary

  • 25.1 Key Takeaways
  • 25.2 Strategic Recommendations

26 Quantitative Summary

  • 26.1 Geography
    • 26.1.1 North America: Delivery Mode
    • 26.1.2 North America: Functionality
    • 26.1.3 North America: Application
    • 26.1.4 North America: End-User
    • 26.1.5 Europe: Delivery Mode
    • 26.1.6 Europe: Functionality
    • 26.1.7 Europe: Application
    • 26.1.8 Europe: End-User
    • 26.1.9 APAC: Delivery Mode
    • 26.1.10 APAC: Functionality
    • 26.1.11 APAC: Application
    • 26.1.12 APAC: End-User
    • 26.1.13 Latin America: Delivery Mode
    • 26.1.14 Latin America: Functionality
    • 26.1.15 Latin America: Application
    • 26.1.16 Latin America: End-User
    • 26.1.17 Middle East & Africa: Delivery Mode
    • 26.1.18 Middle East & Africa: Functionality
    • 26.1.19 Middle East & Africa: Application
    • 26.1.20 Middle East & Africa: End-User
  • 26.2 Delivery Mode
    • 26.2.1 On-Premises
    • 26.2.2 Cloud-Based
  • 26.3 Functionality
    • 26.3.1 Genome Sequencing
    • 26.3.2 Gene Editing
    • 26.3.3 Others
  • 26.4 Application
    • 26.4.1 Translational Precision Medicine
    • 26.4.2 Clinical & Genomic Diagnostics
    • 26.4.3 Other Applications
  • 26.5 End-User
    • 26.5.1 Pharma & Biotech Companies
    • 26.5.2 Public & Consumer Genomic Centers
    • 26.5.3 Others

27 Appendix

  • 27.1 Abbreviations